Ontology highlight
ABSTRACT:
SUBMITTER: Dong Y
PROVIDER: S-EPMC6318024 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Dong Yiyu Y Eskandari Roozbeh R Ray Chelsea C Granlund Kristin L KL Santos-Cunha Lidia Dos LD Miloushev Vesselin Z VZ Tee Sui Seng SS Jeong Sangmoo S Aras Omer O Chen Ying-Bei YB Cheng Emily H EH Hsieh James J JJ Keshari Kayvan R KR
Cancer research 20181120 1
The ever-changing tumor microenvironment constantly challenges individual cancer cells to balance supply and demand, presenting tumor vulnerabilities and therapeutic opportunities. Everolimus and temsirolimus are inhibitors of mTOR (mTORi) approved for treating metastatic renal cell carcinoma (mRCC). However, treatment outcome varies greatly among patients. Accordingly, administration of mTORi in mRCC is diminishing, which could potentially result in missing timely delivery of effective treatmen ...[more]